You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS
[BOM: 500420|NSE : TORNTPHARM]

Financials based on Standalone/Consolidated numbers

Check out Industry Peers

Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS 1.5% 7.8% 15.5%
SUN PHARMACEUTICAL INDUSTRIES 2.8% 10.2% 40.1%
DR REDDYS LABORATORIES 7.8% 18.3% 26.4%
DIVIS LABORATORIES 1.7% 12% 63.2%
CIPLA 7.2% 22.8% 58.3%
BIOCON -1.4% 3.4% 14.3%
AUROBINDO PHARMA 8.5% 17.7% 77.9%
LUPIN 5.1% 6.9% 28.9%
CADILA HEALTHCARE 13.8% 29.7% 58%

Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Profit & Loss Statement of TORRENT PHARMACEUTICALS
[BOM: 500420|NSE : TORNTPHARM]

Debt Ratio of TORRENT PHARMACEUTICALS
[BOM: 500420|NSE : TORNTPHARM]

Efficiency Ratios of TORRENT PHARMACEUTICALS
[BOM: 500420|NSE : TORNTPHARM]

Cashflow Statement of TORRENT PHARMACEUTICALS
[BOM: 500420|NSE : TORNTPHARM]

TORRENT PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 4.4% 13% 55.2%
S&P BSE MOMENTUM 1.8% 8.6% 34.7%
S&P BSE MIDSMALLCAP -0.3% -0.3% 79.7%
S&P BSE MID CAP -0.4% -0.9% 67.2%
S&P BSE MIDCAP SELECT INDEX -0.5% -1.7% 59.5%
S&P BSE SENSEX NEXT 50 -0.5% -2% 53.1%
S&P BSE ALLCAP -1.1% -2.1% 60%
S&P BSE 250 LARGEMIDCAP -1.1% -2.2% 57.5%
S&P BSE 500 -1.1% -2.2% 59.1%
S&P BSE 200 -1.1% -2.2% 57.2%
S&P BSE LARGE MIDCAP -1.2% -2.5% 55.9%
S&P BSE CARBONEX -1.3% -2.8% 56.5%
S&P BSE 100 LARGECAP TMC -1.3% -2.5% 54.3%
S&P BSE 100 -1.3% -2.7% 54.6%
NSE Indices1W1M1Y
NIFTY PHARMA 4.8% 13.9% 44.8%
NIFTY LARGE MIDCAP 250 0.5% -3.4% 72.3%
NIFTY NEXT 50 0.4% 0.3% 44.8%
NIFTY ALPHA LOW-VOLATILTY 30 0.1% 3.1% 42.2%
NIFTY 500 -1.1% -2.2% 58.6%
NIFTY 200 -1.1% -2.2% 56.2%
NIFTY 100 -1.2% -2.4% 53.5%

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z